Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
autologous multi-lineage potential cells
- Development stage
- Phase 1
- Lead developer
- Lai Fung Holdings
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
Autologous Multi-lineage Potential Cells (AMPC) are a cell therapy product consisting of stem-like cells isolated from a patient's own peripheral blood. Developed by Lai Corporation, these cells are characterized by their ability to differentiate into various cell types, a property known as multi-lineage potential. In the context of hematological oncology, specifically relapsed or refractory acute myeloid leukemia (AML), AMPCs are being investigated for their potential to reconstitute or modulate the immune system and provide therapeutic benefit. The cells are harvested from the patient, processed, and then re-administered as an autologous transplant to evaluate safety and clinical response in advanced leukemia cases.
- Other names
- Peripheral Blood Derived Autologous Multi-lineage Potential Cells
Beyond the preview
Go deeper on autologous multi-lineage potential cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on autologous multi-lineage potential cells.